David P. Southwell
CEO, Volastra Therapeutics · PTC Therapeutics
What this record rests on
Company-stated
Name and title were read from a page on the company's own website. IC360 has not independently verified them.
- Name
- David P. Southwell
- Title as stated
- CEO, Volastra Therapeutics
- Company
- PTC Therapeutics
- Source page
- ptcbio.com/about-ptc/leadership/ read on October 4, 2026
Inferred by IC360
Derived from the stated title by IC360; treat as indicative.
- Normalised role
- CEO
- Level
- C-level
- Department
- Executive Management
Verified facts
None yet. No field on this record has been independently verified.
Not published
Contact details, biography and photo are not part of this record and are not shown.
Also listed at PTC Therapeutics
Joeli Mansim
Head of LATAM
Hege Sollie-Zetlmayer
Former Chief Human Resources Officer – PTC Therapeutics
Emma Reeve
Independent Board Director
Former SVP
Head of North America, Rare Disease – Genzyme
Christine Utter
Senior Vice President, Chief Accounting Officer and Head of People Services
Patrice Thornton
Senior Vice President, Human Resources
Linda Montella-Carter
Senior Vice President and Chief Information Officer at PTC Therapeutics
Mary Frances Harmon
Senior Vice President, Corporate and Patient Relations at PTC Therapeutics
Pierre Gravier
Chief Financial Officer at PTC Therapeutics
Lee Golden
Chief Medical Officer at PTC Therapeutics
Mark Boulding
Executive Vice President and Chief Legal Officer at PTC Therapeutics
Neil Almstead, Ph.D.
Chief Technical Operations Officer
